Krzysztof M. Nowak MD, will care for patients at ENTA’s Yonkers and Tuckahoe offices. He received his Medical Degree from the Medical University of Warsaw, Poland. He completed a pediatric residency in the Department of Pulmonary and Allergic Diseases at the Warsaw Medical School Children’s Hospital. He chose to continue his training at The New York Presbyterian Hospital - Cornell Weill Medical College where he finished a residency program in pediatrics followed by a fellowship in Allergy and Immunology During this fellowship, Dr. Nowak received intense cross-training in pulmonary medicine, which greatly enhances his ability to care for the respiratory diseases found in patients with allergy and asthma. He is board certified in Pediatrics and Allergy and Immunology.
Dr. Nowak is dedicated to providing high quality, personalized care to both, children and adults with allergy, asthma and immunologic diseases. In addition, Dr. Nowak is fluent in English, Polish and Spanish.
“We are delighted to add Dr. Krzysztof M. Nowak to the roster of Board Certified allergists here at ENT and Allergy Associates", said Wayne Eisman, MD, president of ENT and Allergy Associates. "His clinical acumen allows us to provide the highest level of care to our patients in Yonkers and Tuckahoe, and his multi-lingual skills enables us to provide services to a greater number of residents in those communities".
ENT and Allergy Associates, LLP is the largest and most comprehensive ear, nose, throat, allergy and audiology practice in the nation with 35 offices and over 120 physicians. Our offices provide a full complement of services, including General Adult and Pediatric ENT, Voice and Swallowing, Facial Plastics and Reconstructive Surgery, Disorders of the Inner Ear and Dizziness, Asthma, Clinical Immunology, Diagnostic Audiology, and Hearing Aid dispensing. Visit www.entandallergy.com for more information. The Practice has a clinical alliance with the Mount Sinai Medical Center for the treatment of diseases of the head and neck and a partnership with the American Cancer Society to educate and treat patients with smoking disorders and cancer. The Practice has also expanded its clinical capabilities to include advanced Immunodeficiency trials.